Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium

Core Insights - Aquestive Therapeutics, Inc. is participating in the Piper Sandler Spring Biopharma Symposium in Boston, with investor meetings scheduled for April 17, 2025 [1] Company Overview - Aquestive is a pharmaceutical company focused on advancing medicines through innovative science and delivery technologies, aiming to improve patients' lives [2] - The company is developing orally administered and topical gel products to deliver complex molecules, providing alternatives to standard therapies [2] - Currently, Aquestive has four commercialized products marketed by licensees in the U.S. and globally, and it is the exclusive manufacturer of these products [2] - The company collaborates with other pharmaceutical companies to bring new molecules to market using proprietary technologies like PharmFilm® [2] - Aquestive is advancing a late-stage proprietary product candidate for treating severe allergic reactions, including anaphylaxis, and an early-stage epinephrine prodrug topical gel for dermatology conditions [2]